Emerging from the UK, retatrutide, a new peptide , is generating considerable buzz within the medical community regarding its ability for weight control . This dual GIP and GLP-1 target agonist looks to provide a substantial advantage over existing therapies, showing positive results in initial clinical trials . Researchers think its distinctive me